NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer.

Yi, Lili; Lei, Yongqiang; Yuan, Fengjiao; Tian, Conghui; Chai, Jian; Gu, Mingliang

Yi, Lili; Lei, Yongqiang; Yuan, Fengjiao; Tian, Conghui; Chai, Jian; Gu, Mingliang.

Afiliación

Yi L; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China.
Lei Y; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China.
Yuan F; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China.
Tian C; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China.
Chai J; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China. chaijian1989@126.com.
Gu M; Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China. minglianggu@hotmail.com.

Sci Rep ; 12(1): 10567, 2022 06 22.

Article en En | MEDLINE | ID: mdl-35732855

Asunto(s)

Neoplasias de la Mama; Netrinas; Biomarcadores de Tumor/genética; Biomarcadores de Tumor/metabolismo; Neoplasias de la Mama/patología; Linfocitos T CD8-positivos/metabolismo; Femenino; Humanos; Inmunohistoquímica; Netrinas/genética; Pronóstico; Análisis de Supervivencia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Netrinas Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google